Range Nuclear Renaissance ETF vs Koninklijke Philips NV — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Koninklijke Philips NV trades at $24.07 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 33.7× Range Nuclear Renaissance ETF's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Range Nuclear Renaissance ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 17 Days and Koninklijke Philips NV for 84 Days on average.
| NUKZ | PHG | |
|---|---|---|
Market Cap | $698.21M | $23.52B |
Volume | 57,444 | 1,635,069 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $32.91 |
52-Week Low | $60.23 | $23.81 |
Typical Hold Time | 17 Days | 84 Days |
Enterprise Value | — | $29.87B |
Dividend Yield | — | 4.17% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PHG trades at $24.225, up 0.56% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent news highlights Philips' innovation in healthcare technology including new product launches and strategic partnerships.
While valuation appears reasonable with P/E of 18.94 and EV/EBITDA of 8.86, the stock faces headwinds from bearish technical indicators and mixed analyst sentiment. Investment opportunity lies in continued earnings momentum and healthcare technology leadership, balanced against competitive pressures and execution risks in a challenging market environment.
Trailing returns across standard periods
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →